ACG North America Expanding its reach in North America in 2017

ACG North America is the U.S. branch offices of ACG Worldwide, the second largest capsule manufacturer in the world and the only company to offer pharmaceutical, OTC and dietary supplement companies a full range of capsules, blister packing films, and machines - capsule fillers, tablet presses, blister packing and cartoning.

In 2017, North America will represent 25% of ACG's sales worldwide.

In 2017, ACG's goals are:

  • Creating a single brand that includes all products.
  • Build ACG’s reputation as a single-source supplier.
  • Showcase ACG as a Solutions Provider.
  • Create preference for the ACG brand.

Experience ACG Campaign

The Experience ACG theme could highlight the company's extensive experience in each product area as well as your experience in providing solutions. For customers & prospects, you could discuss the ACG Customer Experience, which would touch on technical support, your new product showcase in New Jersey and your partnership with Xertecs.

ACG North America Target Audiences

  • Pharmaceutical manufacturers
  • Nutraceutical manufacturers
  • Packaging companies

Suggested Tactics:


Advertising in Tablets & Capsules Magazine, Natural Products Insider, Packaging Digest, & Pharmaceutical & Medical Packaging will help you reach your target audiences.

Most important is to be included in the Buyers' Guides of top publications. If you are only advertising sporadically, those are the issues to target.

Trade Shows

To increase the effectiveness of your tradeshow experience GoldsmithPR can send out press releases, direct email to customers, and set up interviews with trade media at the show.

In addition to exhibiting, ACG should consider securing speaking opportunities at the shows which will promote ACG's leadership in the industry.

Direct Mail

Can be used to promote ACG Solutions to customers and prospects, such as ACG's DPI offerings. When we sent direct email in the past, we had strong open and click through rates. GoldsmithPR strongly recommends HTML emails that have live links to specific products rather than PDF files.

Solutions emails could highlight several product lines and reinforce the "Experience" theme.

DPIs are a safe and effective method for managing respiratory diseases by delivering drugs directly to the lungs. ACG’s holistic capsule Dry Powder Inhalation (cDPI) solution is one such success story of an integrated solution using:

  • ACG Associated Capsule's Ezeeflo™ DPI capsules
  • ACG’s cDPI Formulation Expertise
  • ACG Pam’s ZRO Microfill-Encapsulation Technology for DPI
  • ACG Pharmapack’s Packaging Solutions for inhalation capsules

Public Relations

Press releases are the most cost effective and efficient way to disseminate information. Once printed in a trade publication (or magazine website) they are validated as newsworthy.

Goldsmith PR suggest sending out more North American specific releases.

Feature articles are also highly effective at disseminating your key messages. Typically they generate more leads than advertisements. GoldsmithPR can help you turn White Papers and presentations into articles. We can also set up interviews with trade publications to make sure you are included in "round up" issues.

ACG North America Website

1n 2016, the team looked at the North American website with the hope of re-designing it to emphasize solutions, in line with the worldwide site which is organized by manufacturing solutions, packaging solutions and R&D solutions.

The ACG North America Site hasn't been updated since it's initial launch. Information is out of date and does not reflect the concept of "Solutions".

Proposed Information Architecture

New pages were written and submitted in October 2016. They were reviewed by team members for accuracy.


A refreshed ACG North America Site would also stay current with North America specific shows and events.


Report Abuse

If you feel that this video content violates the Adobe Terms of Use, you may report this content by filling out this quick form.

To report a Copyright Violation, please follow Section 17 in the Terms of Use.